BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 32308350)

  • 1. Preoperative gamma-glutamyltransferase to lymphocyte ratio predicts long-term outcomes in intrahepatic cholangiocarcinoma patients following hepatic resection.
    Wang JJ; Li H; Li JX; Xu L; Wu H; Zeng Y
    World J Gastroenterol; 2020 Apr; 26(13):1501-1512. PubMed ID: 32308350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Albumin to gamma-glutamyltransferase ratio as a prognostic indicator in intrahepatic cholangiocarcinoma after curative resection.
    Jing CY; Fu YP; Shen HJ; Zheng SS; Lin JJ; Yi Y; Huang JL; Xu X; Zhang J; Zhou J; Fan J; Ren ZG; Qiu SJ; Zhang BH
    Oncotarget; 2017 Feb; 8(8):13293-13303. PubMed ID: 28076328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative impact of preoperative platelet-lymphocyte ratio on outcome after hepatic resection for intrahepatic cholangiocarcinoma.
    Chen Q; Dai Z; Yin D; Yang LX; Wang Z; Xiao YS; Fan J; Zhou J
    Medicine (Baltimore); 2015 Apr; 94(13):e574. PubMed ID: 25837750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of sarcopenia combined with preoperative fibrinogen-albumin ratio in patients with intrahepatic cholangiocarcinoma after surgery: A multicenter, prospective study.
    Yu H; Wang M; Wang Y; Yang J; Deng L; Bao W; He B; Lin Z; Chen Z; Chen K; Zhang B; Liu F; Yu Z; Ye L; Jin B; Chen G
    Cancer Med; 2021 Jul; 10(14):4768-4780. PubMed ID: 34105304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
    Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
    Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of neutrophil/prealbumin ratio for intrahepatic cholangiocarcinoma undergoing curative resection.
    Huang XT; Huang CS; Li JH; Cai JP; Chen W; Yin XY
    HPB (Oxford); 2018 Dec; 20(12):1215-1222. PubMed ID: 30078755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the Preoperative C-reactive Protein to Albumin Ratio on the Long-Term Outcomes of Hepatic Resection for Intrahepatic Cholangiocarcinoma.
    Ito T; Shinkawa H; Takemura S; Tanaka S; Nishioka T; Miyazaki T; Ishihara A; Kubo S
    Asian Pac J Cancer Prev; 2020 Aug; 21(8):2373-2379. PubMed ID: 32856868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Preoperative Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios on Survival in Patients with Extrahepatic Cholangiocarcinoma.
    Kitano Y; Yamashita YI; Yamamura K; Arima K; Kaida T; Miyata T; Nakagawa S; Mima K; Imai K; Hashimoto D; Chikamoto A; Baba H
    Anticancer Res; 2017 Jun; 37(6):3229-3237. PubMed ID: 28551669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative risk score for prediction of long-term outcomes after hepatectomy for intrahepatic cholangiocarcinoma: Report of a collaborative, international-based, external validation study.
    Brustia R; Langella S; Kawai T; Fonseca GM; Schielke A; Colli F; Resende V; Fleres F; Roulin D; Leyman P; Giacomoni A; Granger B; Fartoux L; De Carlis L; Demartines N; Sommacale D; Sanches MD; Patrono D; Detry O; Herman P; Okumura S; Ferrero A; Scatton O;
    Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):560-571. PubMed ID: 31718919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Declined Preoperative Aspartate Aminotransferase to Neutrophil Ratio Index Predicts Poor Prognosis in Patients with Intrahepatic Cholangiocarcinoma after Hepatectomy.
    Liu L; Wang W; Zhang Y; Long J; Zhang Z; Li Q; Chen B; Li S; Hua Y; Shen S; Peng B
    Cancer Res Treat; 2018 Apr; 50(2):538-550. PubMed ID: 28602056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The prognostic value of preoperative peripheral blood inflammatory biomarkers for intrahepatic cholangiocarcinoma after radical resection].
    Li Q; Zhang R; Fu JL; Zhang J; Su JB; Jin ZC; Chen C; Zhang D; Geng ZM
    Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1194-1201. PubMed ID: 36380668
    [No Abstract]   [Full Text] [Related]  

  • 12. Development and Validation of a Laboratory Risk Score (LabScore) to Predict Outcomes after Resection for Intrahepatic Cholangiocarcinoma.
    Tsilimigras DI; Mehta R; Aldrighetti L; Poultsides GA; Maithel SK; Martel G; Shen F; Koerkamp BG; Endo I; Pawlik TM;
    J Am Coll Surg; 2020 Apr; 230(4):381-391.e2. PubMed ID: 32014569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The Predictive Value of Perioperative Inflammatory Indicatorsin Prognosis of the Intrahepatic Cholangiocarcinoma Patients after Hepatectomy].
    Zhang ZF; Wang T; Kong JJ; Yang LP; Yang XW; Wang WT
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):403-410. PubMed ID: 32543151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new prognostic scoring system using factors available preoperatively to predict survival after operative resection of perihilar cholangiocarcinoma.
    Saito H; Noji T; Okamura K; Tsuchikawa T; Shichinohe T; Hirano S
    Surgery; 2016 Mar; 159(3):842-51. PubMed ID: 26683498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of resection margin length after surgical resection for intrahepatic cholangiocarcinoma.
    Zhu H; Wang L; Wang M; He X; Xu W; Zhu W; Zhao Y; Wang L
    Am J Surg; 2021 Aug; 222(2):383-389. PubMed ID: 33388133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of systemic immune-inflammation index in patients with intrahepatic cholangiocarcinoma undergoing hepatic resection.
    Li H; Wang JJ; Zhang M; Ren B; Li JX; Xu L; Wu H
    World J Gastrointest Oncol; 2020 Apr; 12(4):467-482. PubMed ID: 32368324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High C-reactive protein/albumin ratio associated with reduced survival due to advanced stage of intrahepatic cholangiocarcinoma.
    Kano H; Midorikawa Y; Song P; Nakayama H; Moriguchi M; Higaki T; Tsuji S; Takayama T
    Biosci Trends; 2020 Sep; 14(4):304-309. PubMed ID: 32507777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio among patients with intrahepatic cholangiocarcinoma.
    Buettner S; Spolverato G; Kimbrough CW; Alexandrescu S; Marques HP; Lamelas J; Aldrighetti L; Gamblin TC; Maithel SK; Pulitano C; Weiss M; Bauer TW; Shen F; Poultsides GA; Marsh JW; IJzermans JNM; Koerkamp BG; Pawlik TM
    Surgery; 2018 Sep; 164(3):411-418. PubMed ID: 29903509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of KRAS Variant Subtypes With Survival and Recurrence in Patients With Surgically Treated Intrahepatic Cholangiocarcinoma.
    Zhou SL; Xin HY; Sun RQ; Zhou ZJ; Hu ZQ; Luo CB; Wang PC; Li J; Fan J; Zhou J
    JAMA Surg; 2022 Jan; 157(1):59-65. PubMed ID: 34730772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of gamma-glutamyl transpeptidase to albumin ratio in patients with intrahepatic cholangiocarcinoma after hepatectomy.
    Li H; Liu R; Li J; Li J; Wu H; Wang G; Li Z; Li D
    J Cell Mol Med; 2022 Jun; 26(11):3196-3202. PubMed ID: 35481993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.